These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12409149)

  • 1. Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats.
    Satoh Si; Ikegaki I; Toshima Y; Watanabe A; Asano T; Shimokawa H
    Life Sci; 2002 Nov; 72(1):103-12. PubMed ID: 12409149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rho-kinase by hydroxyfasudil prevents vasopressin-induced myocardial ischemia in Donryu rats by attenuating coronary vasoconstriction.
    Vincelette J; Pagila R; Kawai K; Ishii M; Horimizu Y; Vergona R; Sullivan ME; Morser J; Dole WP; Wang YX
    Pharmacology; 2005 Nov; 75(3):145-51. PubMed ID: 16158013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
    Shimokawa H; Hiramori K; Iinuma H; Hosoda S; Kishida H; Osada H; Katagiri T; Yamauchi K; Yui Y; Minamino T; Nakashima M; Kato K
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):751-61. PubMed ID: 12409984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiischemic properties of fasudil in experimental models of vasospastic angina.
    Sato S; Ikegaki I; Asano T; Shimokawa H
    Jpn J Pharmacol; 2001 Sep; 87(1):34-40. PubMed ID: 11676196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor.
    Toshima Y; Satoh S; Ikegaki I; Asano T
    Stroke; 2000 Sep; 31(9):2245-50. PubMed ID: 10978059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.
    Mohri M; Shimokawa H; Hirakawa Y; Masumoto A; Takeshita A
    J Am Coll Cardiol; 2003 Jan; 41(1):15-9. PubMed ID: 12570938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina.
    Utsunomiya T; Satoh S; Ikegaki I; Toshima Y; Asano T; Shimokawa H
    Br J Pharmacol; 2001 Dec; 134(8):1724-30. PubMed ID: 11739249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
    Fukumoto Y; Mohri M; Inokuchi K; Ito A; Hirakawa Y; Masumoto A; Hirooka Y; Takeshita A; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):117-21. PubMed ID: 17414222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice.
    Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Kaibuchi K; Takeshita A
    Circ Res; 2004 Jan; 94(1):46-52. PubMed ID: 14615290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
    Satoh S; Utsunomiya T; Tsurui K; Kobayashi T; Ikegaki I; Sasaki Y; Asano T
    Life Sci; 2001 Aug; 69(12):1441-53. PubMed ID: 11531167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
    Demiryürek S; Kara AF; Celik A; Babül A; Tarakçioglu M; Demiryürek AT
    Eur J Pharmacol; 2005 Dec; 527(1-3):129-40. PubMed ID: 16307738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
    Masumoto A; Mohri M; Shimokawa H; Urakami L; Usui M; Takeshita A
    Circulation; 2002 Apr; 105(13):1545-7. PubMed ID: 11927519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
    J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris.
    Otsuka T; Ibuki C; Suzuki T; Ishii K; Kodani E; Atarashi H; Kishida H; Takano T
    Circ J; 2006 Apr; 70(4):402-8. PubMed ID: 16565555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.
    Washida N; Wakino S; Tonozuka Y; Homma K; Tokuyama H; Hara Y; Hasegawa K; Minakuchi H; Fujimura K; Hosoya K; Hayashi K; Itoh H
    Nephrol Dial Transplant; 2011 Sep; 26(9):2770-9. PubMed ID: 21378147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.
    Abe K; Shimokawa H; Morikawa K; Uwatoku T; Oi K; Matsumoto Y; Hattori T; Nakashima Y; Kaibuchi K; Sueishi K; Takeshit A
    Circ Res; 2004 Feb; 94(3):385-93. PubMed ID: 14670839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
    Guan SJ; Ma ZH; Wu YL; Zhang JP; Liang F; Weiss JW; Guo QY; Wang JY; Ji ES; Chu L
    Food Chem Toxicol; 2012 Jun; 50(6):1874-82. PubMed ID: 22429817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.